-
Protease Inhibitor Cocktail EDTA-Free: Protocol Guide
2026-09-29
Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) helps limit endogenous proteolysis during protein extraction and sample preparation while avoiding EDTA-mediated chelation. It is suited to lysate-based workflows such as Western blotting, co-immunoprecipitation, pull-down assays, and kinase assays, but it should not be treated as a universal inhibitor or as a replacement for phosphatase or EDTA-dependent metalloprotease control.
-
TLR4 Suppression and Microglial Polarization in Heatstroke
2026-09-29
The 2025 study by Wu et al. shows that pharmacological TLR4 inhibition with TAK-242 reduces neurological dysfunction, cerebral edema, cognitive impairment, and hippocampal pathology in heatstroke rats. Its central contribution is linking TLR4–MyD88–NF-κB signaling with a shift in microglial polarization from pro-inflammatory markers toward an anti-inflammatory profile.
-
PBS (Phosphate-Buffered Saline): Workflow Guide
2026-09-28
PBS (Phosphate-Buffered Saline), SKU K2818, provides a sterile, isotonic buffer for cell washing, compatible reagent dilution, and routine in vitro handling where controlled pH and ionic conditions are required. It is intended for scientific research only and should not be used for diagnostic or medical procedures or treated as a substitute for growth medium or assay-specific buffers.
-
2-Deoxy-D-glucose and the Lactate–Senescence Axis
2026-09-28
Explore how 2-Deoxy-D-glucose can help test the relationship between glycolytic activity, lactate-associated chromatin signaling, and senescence in non-small cell lung cancer. This article connects recent KRT19 findings to practical assay design while clarifying what 2-DG can—and cannot—show.
-
Anti-DYKDDDDK (Flag) Magnetic Beads Workflow
2026-09-27
Anti-DYKDDDDK (Flag) Magnetic Beads capture DYKDDDDK (Flag) tag fusion proteins for small-scale purification, immunoprecipitation, and co-immunoprecipitation from complex samples. They are intended for targets carrying this tag, not for general protein enrichment or tag-free targets; binding and recovery should be checked in the user’s sample and assay conditions.
-
PTC124 (Ataluren) in Lowe Syndrome Cell Assays
2026-09-26
Use PTC124 (Ataluren) as a testable readthrough strategy only when an OCRL model carries a premature stop-codon variant—not as a substitute for gene correction or augmentation. This workflow pairs a controlled dose-and-time screen with OCRL protein, enzyme, and trabecular-meshwork phenotype measurements so a null result can be interpreted rather than simply discarded.
-
METTL16–SENP3–LTF Drives Ferroptosis Resistance in HCC
2026-09-25
Wang et al. identify an m6A-dependent METTL16–SENP3–LTF pathway that lowers labile iron and limits ferroptosis in hepatocellular carcinoma (HCC). Evidence from cell models, organoids, mouse models, and human samples connects this mechanism to tumor progression and poor prognosis, while suggesting a potential route to sensitize HCC to ferroptosis.
-
D-Luciferin Workflows for CRC Metastasis Imaging
2026-09-25
Connect colorectal cancer metastasis biology to longitudinal reporter imaging with a practical D-Luciferin workflow. Learn how to separate tumor-burden readouts from promoter activity and ATP measurements, and how to troubleshoot the variables that shape light output.
-
MCC950 Sodium for Endothelial Pyroptosis Research
2026-09-24
Use MCC950 sodium to test whether NLRP3 activity contributes to oxidative-stress-induced endothelial injury, then extend the same mechanistic question to macrophage and autoimmune disease research. The article’s HUVEC conditions offer a literature-grounded starting point, while practical controls help distinguish NLRP3-dependent effects from general cell injury.
-
RNA m6A Homeostasis: From Mechanism to Translation
2026-09-24
A mechanistic study links arginine methylation, the SMN–METTL14 interaction, and m6A deposition on DNA repair transcripts. This article explores how translational researchers can build on that evidence with complementary RNA tools, including carefully controlled biotinylated RNA workflows.
-
Bleomycin Sulfate: From DNA Damage to Fibrosis
2026-09-23
Explore how Bleomycin Sulfate connects DNA injury to fibrotic biology, and how translational researchers can design more interpretable cancer and fibrosis models.
-
TAK-242 (Resatorvid): Translational TLR4 Strategy
2026-09-23
A thought-leadership guide to using TAK-242 (Resatorvid) to interrogate TLR4 biology, validate inflammatory mechanisms, and design more disciplined translational studies across cardiometabolic and neuroinflammatory models.
-
Cycloheximide as a Translation-Dependence Probe
2026-09-22
Cycloheximide is a protein biosynthesis inhibitor that can reveal whether cancer-cell phenotypes depend on active translation or protein stability. This article connects rigorous Cycloheximide assay design with the RPN1–PD-L1 biology reported in triple-negative breast cancer.
-
Machine Learning for Senolytic Discovery
2026-09-22
The reference study shows that machine-learning models trained on published data can identify senolytic candidates despite small and heterogeneous screening datasets. Its validation of ginkgetin, periplocin, and oleandrin illustrates how computational prioritization can reduce early discovery costs while preserving experimentally testable hypotheses.
-
THZ1 Workflows for CDK7 and Transcription Research
2026-09-21
THZ1 is a covalent CDK7 inhibitor for connecting RNA polymerase II control with measurable changes in transcription, cell proliferation, and apoptosis. This practical guide pairs acute pharmacology with early-transcription assays, T-ALL models, and troubleshooting strategies that distinguish CDK7 effects from parallel RNA Pol II quality-control pathways.